UNITED THERAPEUTICS Corp Quarterly Common Stock, Shares, Issued from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
UNITED THERAPEUTICS Corp quarterly Common Stock, Shares, Issued history and growth rate from Q2 2010 to Q2 2024.
  • UNITED THERAPEUTICS Corp Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 74.5M shares, a 1.31% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 74.5M +965K +1.31% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 74.1M +781K +1.07% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 73.7M +1.01M +1.39% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 73.6M +1.42M +1.97% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 73.5M +1.42M +1.97% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 73.3M +1.41M +1.96% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 72.7M +924K +1.29% Dec 31, 2022 10-K 2024-02-21
Q3 2022 72.2M +542K +0.76% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 72.1M +599K +0.84% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 71.9M +499K +0.7% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 71.7M +601K +0.85% Dec 31, 2021 10-K 2023-02-22
Q3 2021 71.6M +582K +0.82% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 71.5M +534K +0.75% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 71.4M +787K +1.11% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 71.1M +623K +0.88% Dec 31, 2020 10-K 2022-02-24
Q3 2020 71.1M +559K +0.79% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 71M +508K +0.72% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 70.6M +196K +0.28% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 70.5M +296K +0.42% Dec 31, 2019 10-K 2021-02-24
Q3 2019 70.5M +295K +0.42% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 70.5M +286K +0.41% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 70.4M +370K +0.53% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 70.2M +349K +0.5% Dec 31, 2018 10-K 2020-02-26
Q3 2018 70.2M +379K +0.54% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 70.2M +413K +0.59% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 70.1M +360K +0.52% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 69.9M +518K +0.75% Dec 31, 2017 10-K 2019-02-27
Q3 2017 69.8M +532K +0.77% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 69.8M +548K +0.79% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 69.7M +604K +0.88% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 69.3M +353K +0.51% Dec 31, 2016 10-K 2018-02-21
Q3 2016 69.3M +834K +1.22% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 69.2M +1.03M +1.51% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 69.1M +2.64M +3.97% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 69M +3M +4.55% Dec 31, 2015 10-K 2017-02-22
Q3 2015 68.5M +4.22M +6.58% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 68.2M +4.43M +6.96% Jun 30, 2015 10-Q 2015-07-28
Q1 2015 66.5M +3.14M +4.96% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 66M +2.98M +4.72% Dec 31, 2014 10-K 2016-02-25
Q3 2014 64.2M +1.43M +2.28% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 63.8M +1.29M +2.07% Jun 30, 2014 10-Q 2014-07-29
Q1 2014 63.3M +1.05M +1.69% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 63M +931K +1.5% Dec 31, 2013 10-K 2015-02-24
Q3 2013 62.8M +910K +1.47% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 62.5M +820K +1.33% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 62.3M +681K +1.11% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 62.1M +576K +0.94% Dec 31, 2012 10-K 2014-02-25
Q3 2012 61.9M +1.05M +1.73% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 61.6M +828K +1.36% Jun 30, 2012 10-Q 2012-07-26
Q1 2012 61.6M +1.08M +1.79% Mar 31, 2012 10-Q 2012-04-26
Q4 2011 61.5M +1.49M +2.48% Dec 31, 2011 10-K 2013-02-26
Q3 2011 60.8M +1.6M +2.7% Sep 30, 2011 10-Q 2011-10-27
Q2 2011 60.8M +1.96M +3.34% Jun 30, 2011 10-Q 2011-07-28
Q1 2011 60.5M Mar 31, 2011 10-Q 2011-04-28
Q4 2010 60M Dec 31, 2010 10-K 2012-02-28
Q3 2010 59.2M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 58.9M Jun 30, 2010 10-Q 2010-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.